• 1
    Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P, Masini A, et al. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 2000; 95:32003205.
    Direct Link:
  • 2
    Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S, Bolla GB, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26:11311137.
  • 3
    Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24:451459.
  • 4
    Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med 1989; 151:530535.
  • 5
    Finucci G, Desideri A, Sacerdoti D, Bolognesi M, Merkel C, Angeli P, Gatta A. Left ventricular diastolic dysfunction in liver cirrhosis. Scand J Gastroenterol 1996; 31:279284.
  • 6
    Murray JG, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med 1958; 24:358367.
  • 7
    Wong F, Snuderman K, Liu P, Allidina Y, Sherman M, Blendis L. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995; 122:816822.
  • 8
    Azoulay D, Castaing D, Dennison A, Martino W, Eyraud D, Bismuth H. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 1994; 19:129132.
  • 9
    Bernardi M, Trevisani F, Santini C, De Plama M, Gasbarrini G. Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation. Gut 1983; 24:761766.
  • 10
    Wong F, Liu P, Blendis L. Sodium homeostasis with chronic sodium loading in preascitic cirrhosis. Gut 2001; 49:847851.
  • 11
    Henriksen JH, Bendtsen F, Sorensen TI, Stadeager C, Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989; 97:15061513.
  • 12
    Lotterer E, Wengert A, Fleig WE. Transjugular intrahepatic portosystemic shunt : short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis. Hepatology 1999; 29:632639.
  • 13
    Huonker M, Schumacher YO, Ochs A, Sorichter S, Keul J, Rossle M. Cardiac function and hemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 1999; 44:743748.
  • 14
    Colombato LA, Spahr L, Martinet JP, Dufresne MP, Lafortune M, Fenyves D, Pomier-Layrargues G. Hemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients. Gut 1996; 39:600604.
  • 15
    Merli M, Valeriano V, Funaro S, Attili AF, Masini A, Efrati C, De Castro S, et al. Modifications of cardiac function in cirrhotic patients treated with trasnjugular intrahepatic portosystemic shunt (TIPS). Am J Gastroenterol 2002; 97:142148.
    Direct Link:
  • 16
    Arroyo V, Gines P, Gerbes AL, Dudley F, Gentilini P, Laffi G, Reynolds TB, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23:164176.
  • 17
    Shorecky KL, Brenner BM. Body fluid homeostasis in congestive heart failure and cirrhosis with ascites. Am J Med 1982; 72:323338.
  • 18
    Henriksen JH, Moeller S, Ring-Larsen H, Christensen NJ. The sympathetic nervous system in liver disease. J Hepatol 1998; 29:328341.
  • 19
    Henriksen JH, Moller S. Hemodynamics and fluid retention in liver disease. Ital J Gastroenterol Hepatol 1998; 30:320332.
  • 20
    Ginés A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, Angeli P, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111:10021010.
  • 21
    Salerno F, Badalamenti S, Moser P, Lorenzano E, Incerti PL, Dioguardi N. Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large volume paracentesis. Gastroenterology 1990; 98:10631070.
  • 22
    Sahn DJ, DeMaria A, Kisslo, J, Weyman A. Reccomendations regarding quantitation in M-mode echocardiography: results of a survey of ecocardiographic measurements. Circulation 1978; 58:10721083.
  • 23
    Henry WL, DeMaria A, Gramiak R, King DL, Kisslo J, Popp RL, Sahn DJ, et al. Report of the American Society of Echocardiography: nomenclature and standards in two-dimensional echocardiography. Circulation 1980; 62:212217.
  • 24
    Sunagawa K, Maugham WL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983; 245:H773H780.
  • 25
    Kelly RP, Ting C-T, Yang T-M, Liu C-P, Maugham WL, Chang M-S, Kass DA. Effective arterial elastance as index of arterial vascular load in humans. Circulation 1992; 86:513521.
  • 26
    DeSimone G, Roman MJ, Daniels SR, Mureddu G, Kimball TR, Greco R, Devereux RB. Age-related changes in total arterial compliance from birth to maturity in a normotensive population. Hypertension 1997; 29:12131217.
  • 27
    Henriksen JH, Moller S, Schifter S, Bendtsen F. Increased arterial compliance in decompensated cirrhosis. J Hepatol 1999; 31:712718.
  • 28
    Lewis FW, Adair O, Rector WG. Arterial vasodilation is not the cause of increased cardiac output in cirrhosis. Gastroenterology 1992; 102:10241029.
  • 29
    Bhatt DR, Isabel-Jones JB, Villoria GJ, Nakazawa M, Yabek SM, Marks RA, Jarmanaki JM. Accuracy of echocardiography in assessing left ventricular dimensions and volume. Circulation 1978; 57:699707.
  • 30
    Abelmann WH. Hyperdynamic circulation in cirrhosis: a historical perspective. Hepatology 1994; 20:13561358.
  • 31
    Bernardi M, Ruppoli A, Trevisani F, Cancellieri C, Ligabue A, Baraldini M, Gasbarrini G. Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis. Hepatology 1991; 12:207216.
  • 32
    Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis. Gut 2001; 49:268275.
  • 33
    Laffi G, Barletta G, La Villa G, Del Bene R, Riccardi D, Ticali P, Melano L, et al. Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. Gastroenterology 1997; 113:891898.
  • 34
    Sorensen BM, Bille-Brahe NE, Christiansen L, Malmstrom J, Vagn Nielsen O. Hemodynamics in patients undergoing porto-caval shunt operations. Acta Anaesth Scand 1982; 26:425428.
  • 35
    Luca A, Garcia-Pagan JC, de Lacy AM, Escorsell A, Feu F, Visa J, Bosch J, et al. Effects of end-to-side portocaval shunt on systemic and pulmonary hemodynamics in patients with cirrhosis. J Gastroenterol Hepatol 1999; 14:11121118.
  • 36
    Hadengue A, Moreau R, Sogni P, Soupison T, Vilgrain V, Lebrec D. Risk of adverse hemodynamic effects after intrahepatic shunt (TIPS): preliminary results. Hepatology 1992; 16:241A.
  • 37
    Helton WS, Belshaw A, Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg 1993; 5:566571.
  • 38
    Braverman AC, Steiner MA, Picus D, White H. High-output congestive heart failure following transjugular intrahepatic portal-systemic shunting. Chest 1995; 107:14671469.
  • 39
    Möller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 1995; 109:19171925.
  • 40
    Brinch K, Moller S, Bendtsen F, Becker U, Henriksen JH. Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. J Hepatol 2003; 39:2431.
  • 41
    Hadengue A, Moreau R, Gaudin C, Bacq Y, Champigneulle B, Lebrec D. Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion. Hepatology 1992; 15:809815.
  • 42
    Wong F, Logan A, Blendis L. The effect of varying sodium intake on blood volume, forearm blood flow and vascular responsiveness to sympathetic stimulation in pre-ascitic cirrhosis. Clin Invest Med 1996; 19:184194.
  • 43
    Schlant RC, Sonnenblick EH. Normal physiology of the cardiovascular system. In: SchlantRC, AlexanderRW, eds. Hurst's the Heart, Arteries, and Veins, 8th ed. New York: McGraw-Hill, 1994:113151.
  • 44
    Rector WG, Hossack KF. Pathogenesis of sodium retention complicating cirrhosis: is there room for diminished “effective” arterial blood volume? Gastroenterology 1988; 95:16581663.
  • 45
    Katsuta Y, Aramaki T, Sekiyama T, Satomura K, Okumura K. Plasma volume contraction in portal hypertension. J Hepatol 1993; 17(Suppl 2):S19S23.
  • 46
    Grossman WE. Diastolic dysfunction and congestive heart failure. Circulation 1990; 81(Suppl 3):17.
  • 47
    Pozzi M, Osculati G, Boari G, Serboli P, Colombo P, Lambrughi C, De Ceglia S, et al. Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites. Gastroenterology 1994; 106:709719.
  • 48
    Ortega R, Ginés P, Uriz J, Cardenas A, Calahorra B, De Las Heras D, Guevara M, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 2002; 36:941948.
  • 49
    Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz Del Arbol L, Castells L, et al. Effect of plasma volume expansion on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Eng J Med 2000; 119:16371648.
  • 50
    Waxman K, Shoemaker WC. Physiologic determinants of operative survival after portocaval shunt. Ann Surg 1983; 197:7278.